Diagnostic criteria for PHA historically have relied on the detection of increased plasma or serum aldosterone concentration with consequently suppressed plasma renin activity (PRA) and an increased aldosterone‐to‐renin ratio (ARR).2, 3, 4. This evidence concerns the gene REN and Pelger-Huet anomaly.